Why TransCode Therapeutics Inc (RNAZ) Stock Could See Much Higher Prices Ahead

TransCode Therapeutics Inc (NASDAQ: RNAZ) is -90.23% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $27.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RNAZ stock was last observed hovering at around $0.62 in the last trading session, with the day’s gains setting it 0.02%.

Currently trading at $0.64, the stock is 99.69% and 97.58% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.63 million and changing 4.71% at the moment leaves the stock -53.19% off its SMA200. RNAZ registered -97.26% loss for a year compared to 6-month loss of -5.68%. The firm has a 50-day simple moving average (SMA 50) of $0.3216 and a 200-day simple moving average (SMA200) of $1.34203.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 123.76% gain in the last 1 month and extending the period to 3 months gives it a -35.90%, and is 83.48% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 40.60% over the week and 20.67% over the month.

TransCode Therapeutics Inc (RNAZ) has around 10 employees, a market worth around $11.13M and $0.00M in sales. Distance from 52-week low is 198.24% and -97.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-1354.12%).

The EPS is expected to grow by 98.01% this year.

TransCode Therapeutics Inc (RNAZ) Top Institutional Holders

17.0 institutions hold shares in TransCode Therapeutics Inc (RNAZ), with institutional investors hold 11.47% of the company’s shares. The shares outstanding are 17.27M, and float is at 17.23M with Short Float at 5.25%. Institutions hold 11.46% of the Float.